Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Preud'Homme

Showing results (161-170 of 163) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 163 results.
Clinical and Experimental Immunology|January 1, 1997
IL-6 and soluble IL-6 receptors (sIL-6R and sgp130) in human pleural effusions: massive IL-6 production independently of underlying diseasesP Doré, E Lelièvre, F Morel, et al.
Cancer|February 15, 1983
Alpha-chain disease without qualitative serum IgA abnormality. Report of two cases, including a "nonsecretory" formJ C Rambaud, A Galian, F G Danon, et al.
Journal of Immunological Methods|June 21, 1996
Evaluation of monoclonal antibodies with specificity for human IgA, IgA subclasses and allotypes and secretory component. Results of an IUIS/WHO collaborative studyJ Mestecky, R G Hamilton, C G Magnusson, et al.
Pageof 17

Showing results (161-170 of 163) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 163 results.
Clinical and Experimental Immunology|January 1, 1997
IL-6 and soluble IL-6 receptors (sIL-6R and sgp130) in human pleural effusions: massive IL-6 production independently of underlying diseasesP Doré, E Lelièvre, F Morel, et al.
Cancer|February 15, 1983
Alpha-chain disease without qualitative serum IgA abnormality. Report of two cases, including a "nonsecretory" formJ C Rambaud, A Galian, F G Danon, et al.
Journal of Immunological Methods|June 21, 1996
Evaluation of monoclonal antibodies with specificity for human IgA, IgA subclasses and allotypes and secretory component. Results of an IUIS/WHO collaborative studyJ Mestecky, R G Hamilton, C G Magnusson, et al.
Pageof 17